You must be 21 years or older to access this website. All products are for research use only.
Are you 21 years of age or older?
By entering, you confirm that you are at least 21 years old and agree to our terms of service.
For research purposes only. This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Add $38.01 more to save 8% off
Bundle & Save
Discount applies automatically at checkout once your cart subtotal hits the tier.
For In Vitro Research Use Only — Not for Human or Veterinary Use
Intended Use: This product is intended strictly for in vitro laboratory research use only. It is not approved for human or animal use and must not be incorporated into food, drugs, supplements, or cosmetics.
⚠️ Legal Disclaimer: This compound and all associated information have not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding diagnosis, treatment, cure, or prevention of disease. Research use is restricted to qualified professionals in certified laboratory environments.
Terms of Sale: By purchasing from Midwest Peptide, the buyer affirms they are a qualified researcher or institution, fully responsible for the lawful handling, storage, and application of this material. All sales are final.
GHK-Cu capsules contain a research-grade preparation of the copper-binding tripeptide glycyl-histidyl-lysine (GHK) bound to a copper(II) ion, in oral capsule form. The capsule format is studied separately from lyophilized vial preparations because oral and parenteral routes have different absorption profiles. Supplied strictly for Research Use Only.
Lyophilized vials contain freeze-dried GHK-Cu for reconstitution research. Capsules are an oral preparation studied for systemic copper transport and gut-axis research. Published research distinguishes the two delivery routes because absorption and tissue distribution differ between oral and reconstituted forms.
GHK-Cu capsules are studied in preclinical research on copper-dependent enzyme activity, oral copper bioavailability, antioxidant pathway research, and systemic copper homeostasis. All cited studies are conducted in rodent or in-vitro systems consistent with RUO classification.
Other research peptides in this category
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Every batch ships with a third-party COA verifying purity by HPLC (>=99%), identity by mass spectrometry, and per-capsule mass. The batch-specific COA is published on this product page before purchase.
Store sealed at 2-8C, protected from light and humidity. Once the bottle is opened, keep tightly closed and use within the period indicated on the COA. Avoid exposure to direct heat.
GHK-Cu is not FDA-approved as a therapeutic. The capsules supplied here are for laboratory and research use only and are not approved for diagnostic, therapeutic, or human use.
SLU-PP-332 is a small-molecule compound studied in vitro for its activity as a PPARδ/β agonist, with potential relevance in metabolic and performance-focused research. Preliminary findings have examined its effects on endurance capacity, lipid utilization, mitochondrial efficiency, and overall energy expenditure. This oral tablet formulation provides 1 mg per tablet and is supplied in a 60-count bottle, supporting consistent dosing in longer-term laboratory research settings.